FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Cancer Trial Core Patient-Reported Outcomes Guide

FDA publishes a guidance with recommendations for collecting a core set of patient-reported clinical outcomes in cancer clinical trials.

latest-news-card-1
Federal Register

Guide on ANDA Reconsideration Requests

Federal Register notice: FDA makes available a final guidance requesting the reconsideration of an ANDA decision at the division level.

latest-news-card-1
Human Drugs

Staska Pharma Recalls Ascorbic Acid Solution

Staska Pharmaceuticals recalls one lot of ascorbic acid solution for injection (500mg/mL, 50mL vials) due to the presence of glass particulates in som...

latest-news-card-1
Human Drugs

GSK NDA Accepted for New Antibiotic

FDA accepts for priority review a GSK NDA for gepotidacin, a first-in-class oral antibiotic for treating female adults and adolescents with uncomplica...

latest-news-card-1

FDAs Central Role in AI Regulation

FDA commissioner Robert Califf and two colleagues discuss the agencys role in regulating artificial intelligence in biotechnology and healthcare.

latest-news-card-1
Federal Register

Guidance on Temp Policies for Drug Compounding

Federal Register notice: FDA makes available a final guidance entitled Temporary Policies for Compounding Certain Parenteral Drug Products.

Biologics

FDA Holds Novavax Covid/Flu Vaccine IND

FDA places a clinical hold on the Novavax IND for a Covid-19/influenza combination vaccine and influenza standalone vaccine following a report of one ...

latest-news-card-1
Human Drugs

GDUFA Division Level Reconsideration Request

FDA publishes a guidance reflecting GDUFA 3 provisions on the procedures for ANDA applicants to follow in requesting reconsideration of scientific iss...

latest-news-card-1
Medical Devices

FDA Clears Medical AI Imaging Software

FDA clears a Bracco Diagnostics and Subtle Medical 510(k) for their artificial intelligence-powered software AiMify for brain MRIs.

latest-news-card-1
Human Drugs

Novocures Optune Lua for Lung Cancer OKd

Novocure wins PMA approval for Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for treating adult patients with metastatic non-s...